PGD with Comprehensive Chromosomal Screening
With PGD, embryos created by IVF can be tested for genetic abnormalities or chromosome abnormalities so that only those IVF embryos without defects are placed into the uterus.
Additionally, we can greatly reduce the odds of a couple having multiple pregnancies (twins or triplets). It arms clinicians with the knowledge that they are transferring the most chromosomally fit embryo, therefore precluding the need to transfer multiple, unscreened embryos in the hope that one will be healthy enough to create an ongoing pregnancy and a healthy baby.
Today I’m here to talk about a new technique, Pre-plantation Genetic Diagnosis, PGD, with comprehensive chromosomal screening. With this technique, we can test day-five and six embryos to see if they are chromosomally normal. It is important that they are chromosomally normal because most likely a chromosomally abnormal embryo will not make a baby. Therefore, when we test these embryos, we want to see that the embryos are either 46,XX—a normal girl, or 46,XY—a normal boy.
PGD with comprehensive chromosomal screening is a new technique that is being researched extensively. It is our hope that this will enable couples to have higher pregnancy rates with in-vitro fertilization, while lowing in multiple rates, lowering in miscarriage rates, and hopefully having healthier pregnancies. Thank you.
WENDY SCHILLIGNS, MD, FACOG
Dr. Schillings is a board certified reproductive endocrinologist, obstetrician and gynecologist. She leads all aspects of patient care at RMAPA. In addition, she formerly led the medical team at RE & I Specialist with the Lehigh Valley Physician Group. Dr. Schillings is chief of the Division of Reproductive Endocrinology and Infertility at Lehigh Valley Hospital Health Network and Clinical Associate Professor of Obstetrics and Gynecology at Penn State College of Medicine.